1. EP-1552: Robust optimization for IMPT of pencil-beam scanning proton therapy for prostate cancer. (May 2017) Authors: Brouwer, C.L.; Matysiak, W.P.; Klinker, P.; Spijkerman-Bergsma, M.; Hammer, C.; Van den Bergh, A.C.M.; Langendijk, J.A.; Scandurra, D.; Korevaar, E.W. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1834 Feasibility study of extreme hypofractionated proton treatment planning for prostate cancer. (April 2019) Authors: Klinker, P.; Brouwer, C.; Roos, C.; Hammer, C.; Vanhauten, H.; Bijmolt, S.; Langendijk, J.; Both, S.; Van den Bergh, A.; Al-Uwini, S. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0193 Introduction of IMPT for (N)SCLC patients: NTCP model based selection of patients and first results. (August 2021) Authors: Wijsman, R.; Chouvalova, O.; Klinker, P.; Niezink, A.; Van der Leest, A.; Ubbels, F.; Woltman- Van Iersel, M.; Both, S.; Korevaar, E.; Langendijk, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0508 Predicted reduction in ΔNTCP by model based selected proton therapy for oesophageal cancer patients. (May 2022) Authors: Klinker, P.; Korevaar, E.; Koops, A.; Dieters, M.; Mul, V.; Niezink, A.; Langendijk, J.; Muijs, C. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-0667 Introduction of IMPT for NSCLC patients: the learning curve in practice. (May 2022) Authors: Wijsman, R.; Chouvalova, O.; Klinker, P.; Niezink, A.; Van der Leest, A.; Ubbels, F.; Woltman-van Iersel, M.; Both, S.; Korevaar, E.; Langendijk, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PD-0878 Reduction of post-operative toxicity in esophageal cancer patients after model based proton therapy. (August 2021) Authors: Muijs, C.; Dieters, M.; Mul, V.E.; Niezink, A.G.; Schaaf van de, A.; Sijtsema, N.M.; Visser, S.; Klinker, P.; Etten van, B.; Korevaar, E.; Langendijk, J.A. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PH-0330 Introducing IMPT for mediastinal lymphoma: feasibility and NTCP model based selection of patients. (August 2021) Authors: Niezink, A.; Klinker, P.; Busz, D.M.; Beijert, M.; Both, S.; Pisciotta, P.; Korevaar, E.W.; Langendijk, J.A.; Crijns, A.P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-0821: Radiation-induced late rectal toxicity for IMPT vs VMAT in patients with localized prostate cancer. (April 2018) Authors: Hammer, C.; Brouwer, C.L.; Klinker, P.; Both, S.; Aluwini, S.; Langendijk, J.A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-0972 Intrafraction prostate motion effects with or without ERB in highly hypofractionated proton therapy. (April 2019) Authors: Zwart, L.G.M.; Brouwer, C.L.; Klinker, P.; Slump, C.H.; Wang, K.K.; Vapiwala, N.; Langendijk, J.A.; Both, S.; Aluwini, S. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-1879 Trade-off in lung and heart dose and the impact on target robustness in VMAT of oesophageal cancer. (May 2022) Authors: Visser, S.; Schol, M.; Klinker, P.; Dieters, M.; Mul, V.E.; Langendijk, J.A.; Korevaar, E.W.; Both, S.; Muijs, C.T. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗